Assessment of Clopidogrel Resistance in Post Myocardial Infarction Patients after 24 to 48 Hours of Initiation of Treatment: A Cross-sectional Study

Introduction: Clopidogrel is an antiplatelet agent used to prevent platelet aggregation and further blockage of coronary arteries in Acute Coronary Syndrome (ACS) patients. Inadequate response to clopidogrel has been demonstrated in some patients that might lead to re-infarction even when receiv...

Full description

Bibliographic Details
Main Authors: Mayukh Mukherjee, Suhrita Paul, Manasi Basu Banerjee, Sayanti Ghatak, Santanu Guha, Arnab Chattopadhyay
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2021-07-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/15171/49310_CE[Ra1]_F[SK]_PF1(SC_RK)_PFA(KM_Pr)_PN(KM).pdf